Preterm birth buccal cell epigenetic biomarkers to facilitate preventative medicine

Paul Winchester1, Eric Nilsson2, Daniel Beck2

  • 1Department of Pediatrics, St. Franciscan Hospital, School of Medicine, Indiana University, Indianapolis, IN, 46202-5201, USA.

Scientific Reports
|March 2, 2022
PubMed

Insights

This study explored epigenetic biomarkers for preterm birth risk using DNA methylation in mother-father-child triads. Findings suggest both parents contribute epigenetically, with potential inheritance in female children, aiding future preventative strategies.

Area of Science:

  • Genetics and Epigenetics
  • Reproductive Health
  • Perinatal Medicine

Background:

  • Preterm birth is a leading cause of infant mortality, affecting approximately 10% of live births.
  • Current methods for predicting preterm birth susceptibility are limited.
  • Epigenetic factors are increasingly recognized for their role in complex health conditions.

Purpose of the Study:

  • To develop epigenetic biomarkers for preterm birth susceptibility.
  • To investigate the roles of maternal and paternal epigenetic contributions.
  • To explore potential epigenetic inheritance of preterm birth risk.

Main Methods:

  • Epigenome-wide association study (EWAS) on buccal cells from mother-father-child triads.
  • Comparison of DNA methylation patterns between term and preterm birth groups.
  • Identification of differential DNA methylation regions (DMRs).

Main Results:

  • Distinct epigenetic DMR associations with preterm birth identified in both mothers and fathers.
  • Mothers and female children showed the highest number of similar DMRs, suggesting potential epigenetic inheritance.
  • DMR-associated genes included previously identified preterm birth risk genes.
  • Male children showed negligible DMR associations.

Conclusions:

  • Epigenetic factors from both parents may contribute to preterm birth risk.
  • Evidence suggests potential epigenetic inheritance of preterm birth susceptibility, particularly in female offspring.
  • Identified epigenetic biomarkers may facilitate preventative medicine strategies to reduce preterm birth incidence.